Pipeline

A representative sample of the overall Elucida Oncology™ pipeline is shown below.

Image-Guided Sentinel Lymph Node Mapping - Head and Neck Melanoma

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase complete

Phase 1

Phase 1 Phase complete

Phase 2

Phase 2 Phase in progress
Image-Guided Sentinel Lymph Node Mapping - Breast Cancer

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase complete

Phase 1

Phase 1 Phase in progress

Phase 2

Phase 2 Phase not started
PET Imaging

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase in progress

Phase 1

Phase 1 Phase not started

Phase 2

Phase 2 Phase not started
Multiplexing: Tumor & Nerve Tissue

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase in progress

Phase 1

Phase 1 Phase not started

Phase 2

Phase 2 Phase not started
Nanoparticle Drug Conjugates™1

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase in progress

Phase 1

Phase 1 Phase not started

Phase 2

Phase 2 Phase not started
Nanoparticle Radiotherapeutic Conjugates

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase in progress

Phase 1

Phase 1 Phase not started

Phase 2

Phase 2 Phase not started
  1. Nanoparticle Drug Conjugate™ and NDC™ are trademarks of Memorial Sloan Kettering Cancer Center.

Contact Us Today

To learn more about Elucida Oncology™ and our Target or Clear™ development programs.

Contact Us